1-oxa-3,7-diazaspiro[4.5]decan-2-one hydrochloride
95%
- Product Code: 75003
CAS:
1609395-61-0
| Molecular Weight: | 192.64 g./mol | Molecular Formula: | C₇H₁₂N₂O₂ClH |
|---|---|---|---|
| EC Number: | MDL Number: | MFCD20278311 | |
| Melting Point: | Boiling Point: | ||
| Density: | Storage Condition: | 2-8℃ |
Product Description:
This compound is primarily used in the field of medicinal chemistry and pharmaceutical research. It serves as a key intermediate in the synthesis of various biologically active molecules, particularly those targeting neurological and psychiatric disorders. Its spirocyclic structure makes it valuable for developing compounds with enhanced binding affinity and selectivity for specific receptors in the brain. Researchers often utilize it to create potential drug candidates for conditions such as anxiety, depression, and cognitive impairments. Additionally, its unique chemical framework is explored in the design of novel therapeutics for pain management and neurodegenerative diseases. Its application extends to optimizing pharmacokinetic properties, such as stability and bioavailability, in drug development pipelines.
Sizes / Availability / Pricing:
| Size (g) | Availability | Price | Quantity |
|---|---|---|---|
| 1.000 | 10-20 days | Ft622,527.96 |
+
-
|
| 5.000 | 10-20 days | Ft2,281,417.37 |
+
-
|
1-oxa-3,7-diazaspiro[4.5]decan-2-one hydrochloride
This compound is primarily used in the field of medicinal chemistry and pharmaceutical research. It serves as a key intermediate in the synthesis of various biologically active molecules, particularly those targeting neurological and psychiatric disorders. Its spirocyclic structure makes it valuable for developing compounds with enhanced binding affinity and selectivity for specific receptors in the brain. Researchers often utilize it to create potential drug candidates for conditions such as anxiety, depression, and cognitive impairments. Additionally, its unique chemical framework is explored in the design of novel therapeutics for pain management and neurodegenerative diseases. Its application extends to optimizing pharmacokinetic properties, such as stability and bioavailability, in drug development pipelines.
| Mechanism | - |
| Appearance | - |
| Longevity | - |
| Strength | - |
| Storage | - |
| Shelf Life | - |
| Allergen(s) | - |
| Dosage (Range) | - |
| Recommended Dosage | - |
| Dosage (Per Day) | - |
| Recommended Dosage (Per Day) | - |
| Mix Method | - |
| Heat Resistance | - |
| Stable in pH range | - |
| Solubility | - |
| Product Types | - |
| INCI | - |
Cart
No products
Subtotal:
Ft0.00
Ft0.00
Total :